Carlie Tanner, MD, PhD

Title(s)Professor, Neurology
SchoolSchool of Medicine
Address1651 4th Street, #366B
San Francisco CA 94158
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials initiative. J Parkinsons Dis. 2024 Apr 05. Wyse RK, Isaacs T, Barker RA, Cookson MR, Dawson TM, Devos D, Dexter DT, Duffen J, Federoff H, Fiske B, Foltynie T, Fox S, Greenamyre JT, Kieburtz K, Kordower JH, Krainc D, Matthews H, Moore DJ, Mursaleen L, Schwarzschild MA, Stott SRW, Sulzer D, Svenningsson P, Tanner CM, Carroll C, Simon DK, Brundin P. PMID: 38578902.
      View in: PubMed   Mentions:
    2. Extended-release amantadine for OFF-related dystonia in Parkinson's disease. Parkinsonism Relat Disord. 2024 Mar 04; 122:106088. Espay AJ, Ostrem JL, Formella AE, Tanner CM. PMID: 38461688.
      View in: PubMed   Mentions:    Fields:    
    3. Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective Investigation. Mov Disord. 2024 Feb 23. Dorsey ER, Kinel D, Pawlik ME, Zafar M, Lettenberger SE, Coffey M, Auinger P, Hylton KL, Shaw CW, Adams JL, Barbano R, Braun MK, Schwarz HB, Lawrence BP, Kieburtz K, Tanner CM, de Miranda BR, Goldman SM. PMID: 38389433.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Evaluation of ATNPD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease. Neurology. 2024 Feb; 102(4):e208033. Cousins KAQ, Irwin DJ, Tropea TF, Rhodes E, Phillips J, Chen-Plotkin AS, Brumm MC, Coffey CS, Kang JH, Simuni T, Foroud TM, Toga AW, Tanner CM, Kieburtz KD, Mollenhauer B, Galasko D, Hutten S, Weintraub D, Siderowf AD, Marek K, Poston KL, Shaw LM, Parkinson's Progression Markers Initiative. PMID: 38306599.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Racial disparities in hospitalization characteristics among Native Hawaiians, Pacific Islanders and Asian American subgroups with Parkinson's disease. Parkinsonism Relat Disord. 2024 Feb 02; 121:106018. Bruno MK, Matsunaga M, Krening E, Nakagawa K, Chen JJ, Seto T, Gao F, Tanner C, Ross GW. PMID: 38359475.
      View in: PubMed   Mentions:    Fields:    
    6. A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 2024 Feb; 23(2):178-190. Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K. PMID: 38267190.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    7. The epidemiology of Parkinson's disease. Lancet. 2024 Jan 20; 403(10423):283-292. Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. PMID: 38245248.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Prevalence and Incidence of Parkinson's Disease in Latin America: A Meta-Analysis. Mov Disord. 2024 Jan; 39(1):105-118. Kim DJ, Isidro-Pérez AL, Doering M, Llibre-Rodriguez JJ, Acosta I, Rodriguez Salgado AM, Pinilla-Monsalve GD, Tanner C, Llibre-Guerra JJ, Prina M. PMID: 38069493; PMCID: PMC10872644.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Non-steroidal anti-inflammatory drug use and markers of Parkinson's disease progression: A retrospective cohort study. J Neurol Sci. 2023 11 15; 454:120822. Kuhlman G, Auinger P, Duff-Canning S, Lang A, Tanner C, Marras C. PMID: 37839283.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. American Football Play and Parkinson Disease Among Men. JAMA Netw Open. 2023 08 01; 6(8):e2328644. Bruce HJ, Tripodis Y, McClean M, Korell M, Tanner CM, Contreras B, Gottesman J, Kirsch L, Karim Y, Martin B, Palmisano J, Abdolmohammadi B, Shih LC, Stein TD, Stern RA, Adler CH, Mez J, Nowinski C, McKee AC, Alosco ML. PMID: 37566412; PMCID: PMC10422187.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram. Sci Rep. 2023 07 29; 13(1):12290. Karabayir I, Gunturkun F, Butler L, Goldman SM, Kamaleswaran R, Davis RL, Colletta K, Chinthala L, Jefferies JL, Bobay K, Ross GW, Petrovitch H, Masaki K, Tanner CM, Akbilgic O. PMID: 37516770; PMCID: PMC10387090.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Prevalence and impact of neuropsychiatric symptoms in normal aging and neurodegenerative syndromes: A population-based study from Latin America. Alzheimers Dement. 2023 Dec; 19(12):5730-5741. Rodriguez Salgado AM, Acosta I, Kim DJ, Zitser J, Sosa AL, Acosta D, Jimenez-Velasquez IZ, Guerra M, Salas A, Valvuerdi A, Llibre-Guerra JC, Jeyachandran C, Contreras RL, Hesse H, Tanner C, Llibre Rodriguez JJ, Prina M, Llibre-Guerra JJ. PMID: 37427840; PMCID: PMC10776811.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune. JAMA Neurol. 2023 07 01; 80(7):673-681. Goldman SM, Weaver FM, Stroupe KT, Cao L, Gonzalez B, Colletta K, Brown EG, Tanner CM. PMID: 37184848; PMCID: PMC10186205.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    14. Parkinsonism of uncertain clinical significance (PUCS): A proposed new diagnostic entity. J Neurol Sci. 2023 08 15; 451:120696. Zitser J, Brown EG, Ostrem JL, Tanner CM, Rowe JB, Nguyen V, Rosen H, Geschwind MD, Bledsoe IO. PMID: 37352617.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Genome-wide association study identifies a new susceptibility locus in PLA2G4C for Multiple System Atrophy. medRxiv. 2023 May 02. Nakahara Y, Mitsui J, Date H, Porto KJ, Hayashi Y, Yamashita A, Kusakabe Y, Matsukawa T, Ishiura H, Yasuda T, Iwata A, Goto J, Ichikawa Y, Momose Y, Takahashi Y, Toda T, Ohta R, Yoshimura J, Morishita S, Gustavsson EK, Christy D, Maczis M, Farrer MJ, Kim HJ, Park SS, Jeon B, Zhang J, Gu W, Scholz SW, Singleton AB, Houlden H, Yabe I, Sasaki H, Matsushima M, Takashima H, Kikuchi A, Aoki M, Hara K, Kakita A, Yamada M, Takahashi H, Onodera O, Nishizawa M, Watanabe H, Ito M, Sobue G, Ishikawa K, Mizusawa H, Kanai K, Kuwabara S, Arai K, Koyano S, Kuroiwa Y, Hasegawa K, Yuasa T, Yasui K, Nakashima K, Ito H, Izumi Y, Kaji R, Kato T, Kusunoki S, Osaki Y, Horiuchi M, Yamamoto K, Shimada M, Miyagawa T, Kawai Y, Nishida N, Tokunaga K, Dürr A, Brice A, Filla A, Klockgether T, Wüllner U, Tanner CM, Kukull WA, Lee VM, Masliah E, Low PA, Sandroni P, Ozelius L, Foroud T, Tsuji S. PMID: 37425910; PMCID: PMC10327266.
      View in: PubMed   Mentions:
    16. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023 05; 22(5):407-417. Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C, Parkinson's Progression Markers Initiative. PMID: 37059509; PMCID: PMC10627170.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    17. Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study. Mov Disord Clin Pract. 2023 Jun; 10(6):943-955. Weintraub D, Picillo M, Cho HR, Caspell-Garcia C, Blauwendraat C, Brown EG, Chahine LM, Coffey CS, Dobkin RD, Foroud T, Galasko D, Kieburtz K, Marek K, Merchant K, Mollenhauer B, Poston KL, Simuni T, Siderowf A, Singleton A, Seibyl J, Tanner CM, Parkinson's Progression Markers Initiative. PMID: 37332638; PMCID: PMC10272925.
      View in: PubMed   Mentions: 1  
    18. The Impact of the COVID-19 Pandemic on Care Partners of People with Parkinson's Disease. Mov Disord Clin Pract. 2023 Apr; 10(4):596-605. Speelberg DHB, Hulshoff MJ, Book E, Dahodwala N, Korell M, Tanner CM, Marras C. PMID: 37070054; PMCID: PMC10105120.
      View in: PubMed   Mentions:
    19. Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study. J Patient Rep Outcomes. 2023 03 09; 7(1):21. Tanner CM, Caroff SN, Cutler AJ, Lenderking WR, Shalhoub H, Pagé V, Franey EG, Serbin M, Yonan C. PMID: 36892733; PMCID: PMC9998754.
      View in: PubMed   Mentions: 1  Translation:Humans
    20. LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts. NPJ Parkinsons Dis. 2023 Feb 28; 9(1):30. Merchant KM, Simuni T, Fedler J, Caspell-Garcia C, Brumm M, Nudelman KNH, Tengstrandt E, Hsieh F, Alcalay RN, Coffey C, Chahine L, Foroud T, Singleton A, Weintraub D, Hutten S, Sherer T, Mollenhauer B, Siderowf A, Tanner C, Marek K, the Parkinson’s Progression Markers Initiative. PMID: 36854767; PMCID: PMC9974978.
      View in: PubMed   Mentions: 2  
    21. Burden of Parkinsonism and Parkinson's Disease on Health Service Use and Outcomes in Latin America. J Parkinsons Dis. 2023; 13(7):1199-1211. Kim DJ, Rodriguez-Salgado AM, Llibre-Rodriguez JJ, Acosta I, Sosa AL, Acosta D, Jimenez-Velasquez IZ, Guerra M, Salas A, Jeyachandran C, López-Contreras R, Hesse H, Tanner C, Llibre-Guerra JJ, Prina M. PMID: 37742660; PMCID: PMC10657702.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Trichloroethylene: An Invisible Cause of Parkinson's Disease? J Parkinsons Dis. 2023; 13(2):203-218. Dorsey ER, Zafar M, Lettenberger SE, Pawlik ME, Kinel D, Frissen M, Schneider RB, Kieburtz K, Tanner CM, De Miranda BR, Goldman SM, Bloem BR. PMID: 36938742; PMCID: PMC10041423.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    23. Proposal for a Biologic Staging System of Parkinson's Disease. J Parkinsons Dis. 2023; 13(3):297-309. Chahine LM, Merchant K, Siderowf A, Sherer T, Tanner C, Marek K, Simuni T. PMID: 37066922; PMCID: PMC10200239.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    24. What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP). J Parkinsons Dis. 2023; 13(5):757-767. Marras C, Arbatti L, Hosamath A, Amara A, Anderson KE, Chahine LM, Eberly S, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Tanner CM, Weintraub D, Shoulson I. PMID: 37334615; PMCID: PMC10473108.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression. J Parkinsons Dis. 2023; 13(6):899-916. Brumm MC, Siderowf A, Simuni T, Burghardt E, Choi SH, Caspell-Garcia C, Chahine LM, Mollenhauer B, Foroud T, Galasko D, Merchant K, Arnedo V, Hutten SJ, O'Grady AN, Poston KL, Tanner CM, Weintraub D, Kieburtz K, Marek K, Coffey CS, Parkinson’s Progression Markers Initiative. PMID: 37458046; PMCID: PMC10578214.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort. NPJ Parkinsons Dis. 2022 Oct 22; 8(1):140. Simuni T, Merchant K, Brumm MC, Cho H, Caspell-Garcia C, Coffey CS, Chahine LM, Alcalay RN, Nudelman K, Foroud T, Mollenhauer B, Siderowf A, Tanner C, Iwaki H, Sherer T, Marek K, Parkinson’s Progression Marker Initiative Authors. PMID: 36273008; PMCID: PMC9588016.
      View in: PubMed   Mentions: 2  
    27. Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia. Front Neurol. 2022; 13:846126. Pahwa R, Fox S, Hauser RA, Isaacson S, Lytle J, Johnson R, Llorens L, Formella AE, Tanner CM. PMID: 36341088; PMCID: PMC9632663.
      View in: PubMed   Mentions:
    28. Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials. 2022 Oct 06; 23(1):855. Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, McKee KE, Goelz L, Poon C, Tilley B, Kang UJ, Tansey MG, Luthra N, Tanner CM, Haus JM, Fantuzzi G, McFarland NR, Gonzalez-Latapi P, Foroud T, Motl R, Schwarzschild MA, Simuni T, Marek K, Naito A, Lungu C, Corcos DM, SPARX3-PSG Investigators. PMID: 36203214; PMCID: PMC9535216.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    29. Deep Learning for Daily Monitoring of Parkinson's Disease Outside the Clinic Using Wearable Sensors. Sensors (Basel). 2022 Sep 09; 22(18). Atri R, Urban K, Marebwa B, Simuni T, Tanner C, Siderowf A, Frasier M, Haas M, Lancashire L. PMID: 36146181; PMCID: PMC9502239.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Path to Parkinson Disease Prevention: Conclusion and Outlook. Neurology. 2022 08 16; 99(7 Suppl 1):76-83. Berg D, Crotty GF, Keavney JL, Schwarzschild MA, Simuni T, Tanner C. PMID: 35970586.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results. Neurol Genet. 2022 Oct; 8(5):e200008. Jensen-Roberts S, Myers TL, Auinger P, Cannon P, Rowbotham HM, Coker D, Chanoff E, Soto J, Pawlik M, Amodeo K, Sharma S, Valdovinos B, Wilson R, Sarkar A, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Holloway RG, Dorsey ER, Schneider RB. PMID: 35966918; PMCID: PMC9372873.
      View in: PubMed   Mentions: 2  
    32. Trial of Cinpanemab in Early Parkinson's Disease. N Engl J Med. 2022 08 04; 387(5):408-420. Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T, SPARK Investigators. PMID: 35921450.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    33. Enhancing Clinical Information Display to Improve Patient Encounters: Human-Centered Design and Evaluation of the Parkinson Disease-BRIDGE Platform. JMIR Hum Factors. 2022 May 06; 9(2):e33967. Brown EG, Schleimer E, Bledsoe IO, Rowles W, Miller NA, Sanders SJ, Rankin KP, Ostrem JL, Tanner CM, Bove R. PMID: 35522472; PMCID: PMC9123539.
      View in: PubMed   Mentions: 1  
    34. Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease. Neurology. 2022 05 31; 98(22):e2194-e2203. Bock MA, Brown EG, Zhang L, Tanner C. PMID: 35418456; PMCID: PMC9162165.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    35. Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson's disease. NPJ Parkinsons Dis. 2022 Mar 18; 8(1):29. Hauser RA, Lytle J, Formella AE, Tanner CM. PMID: 35304480; PMCID: PMC8933492.
      View in: PubMed   Mentions: 4  
    36. Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study. Lancet Reg Health Am. 2022 Mar; 7:None. Llibre-Guerra JJ, Prina M, Sosa AL, Acosta D, Jimenez-Velazquez IZ, Guerra M, Salas A, Llibre-Guerra JC, Valvuerdi A, Peeters G, Ziegemeier E, Acosta I, Tanner C, Juncos J, Llibre Rodriguez JJ. PMID: 35300390; PMCID: PMC8920908.
      View in: PubMed   Mentions: 9  
    37. The epidemiology of cognitive function in Parkinson's disease. Prog Brain Res. 2022; 269(1):3-37. Bock MA, Tanner CM. PMID: 35248199.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables. J Parkinsons Dis. 2022; 12(1):341-351. Karabayir I, Butler L, Goldman SM, Kamaleswaran R, Gunturkun F, Davis RL, Ross GW, Petrovitch H, Masaki K, Tanner CM, Tsivgoulis G, Alexandrov AV, Chinthala LK, Akbilgic O. PMID: 34602502; PMCID: PMC8842767.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease. J Parkinsons Dis. 2022; 12(1):421-436. Picillo M, LaFontant DE, Bressman S, Caspell-Garcia C, Coffey C, Cho HR, Burghardt EL, Dahodwala N, Saunders-Pullman R, Tanner CM, Amara AW, Parkinson’s Progression Markers Initiative. PMID: 34744052; PMCID: PMC8842783.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    40. Recruitment for Remote Decentralized Studies in Parkinson's Disease. J Parkinsons Dis. 2022; 12(1):371-380. Myers TL, Augustine EF, Baloga E, Daeschler M, Cannon P, Rowbotham H, Chanoff E, 23andMe Research Team, Jensen-Roberts S, Soto J, Holloway RG, Marras C, Tanner CM, Dorsey ER, Schneider RB. PMID: 34744053; PMCID: PMC8842745.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    41. Surveying Global Availability of Parkinson's Disease Treatment. J Parkinsons Dis. 2022; 12(3):1023-1034. Goh ZHK, Cheong JLY, Marras C, Tanner CM, Kasten M, Korczyn AD, Chahine L, Lo R, Noyce AJ, Movement Disorders Society Epidemiology Study Group. PMID: 35147549.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Remote smartphone monitoring of Parkinson's disease and individual response to therapy. Nat Biotechnol. 2022 04; 40(4):480-487. Omberg L, Chaibub Neto E, Perumal TM, Pratap A, Tediarjo A, Adams J, Bloem BR, Bot BM, Elson M, Goldman SM, Kellen MR, Kieburtz K, Klein A, Little MA, Schneider R, Suver C, Tarolli C, Tanner CM, Trister AD, Wilbanks J, Dorsey ER, Mangravite LM. PMID: 34373643.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    43. Bad Air and Parkinson Disease-The Fog May Be Lifting. JAMA Neurol. 2021 07 01; 78(7):793-795. Dorsey ER, Okun MS, Tanner CM. PMID: 33999105.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    44. Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study. J Am Psychiatr Nurses Assoc. 2023 Sep-Oct; 29(5):389-399. Cutler AJ, Caroff SN, Tanner CM, Shalhoub H, Lenderking WR, Pagé V, Franey E, Yonan C. PMID: 34154444; PMCID: PMC10492432.
      View in: PubMed   Mentions: 5     Fields:    
    45. Video-based Parkinson's disease assessments in a nationwide cohort of Fox Insight participants. Clin Park Relat Disord. 2021; 4:100094. Myers TL, Tarolli CG, Adams JL, Barbano R, Cristina Gil-Díaz M, Spear KL, Lowell J, Daeschler M, Riley L, Amondikar N, Auinger P, Marras C, Tanner CM, Ray Dorsey E, Schneider RB. PMID: 34316671; PMCID: PMC8299965.
      View in: PubMed   Mentions: 15  
    46. Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease. Ann Neurol. 2021 07; 90(1):76-88. Lai D, Alipanahi B, Fontanillas P, Schwantes-An TH, Aasly J, Alcalay RN, Beecham GW, Berg D, Bressman S, Brice A, Brockman K, Clark L, Cookson M, Das S, Van Deerlin V, Follett J, Farrer MJ, Trinh J, Gasser T, Goldwurm S, Gustavsson E, Klein C, Lang AE, Langston JW, Latourelle J, Lynch T, Marder K, Marras C, Martin ER, McLean CY, Mejia-Santana H, Molho E, Myers RH, Nuytemans K, Ozelius L, Payami H, Raymond D, Rogaeva E, Rogers MP, Ross OA, Samii A, Saunders-Pullman R, Schüle B, Schulte C, Scott WK, Tanner C, Tolosa E, Tomkins JE, Vilas D, Trojanowski JQ, 23andMe Research Team, Uitti R, Vance JM, Visanji NP, Wszolek ZK, Zabetian CP, Mirelman A, Giladi N, Orr Urtreger A, Cannon P, Fiske B, Foroud T. PMID: 33938021; PMCID: PMC8252519.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    47. Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease. Mov Disord. 2021 08; 36(8):1972-1978. Kremer T, Taylor KI, Siebourg-Polster J, Gerken T, Staempfli A, Czech C, Dukart J, Galasko D, Foroud T, Chahine LM, Coffey CS, Simuni T, Weintraub D, Seibyl J, Poston KL, Toga AW, Tanner CM, Marek K, Hutten SJ, Dziadek S, Trenkwalder C, Pagano G, Mollenhauer B. PMID: 33942926; PMCID: PMC8453505.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    48. Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson's Disease and Dyskinesia. Neurol Ther. 2021 Jun; 10(1):307-320. Mehta SH, Pahwa R, Tanner CM, Hauser RA, Johnson R. PMID: 33864229; PMCID: PMC8140024.
      View in: PubMed   Mentions: 3  
    49. Current Knowledge on the Evolution of Care Partner Burden, Needs, and Coping in Parkinson's Disease. Mov Disord Clin Pract. 2021 May; 8(4):510-520. Hulshoff MJ, Book E, Dahodwala N, Tanner CM, Robertson C, Marras C. PMID: 33981783; PMCID: PMC8088088.
      View in: PubMed   Mentions: 8  
    50. The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. NPJ Parkinsons Dis. 2021 Mar 01; 7(1):16. Tanner CM, Cummings SR, Schwarzschild MA, Brown EG, Dorsey ER, Espay AJ, Galifianakis NB, Goldman SM, Litvan I, Luthra N, McFarland NR, Mitchell KT, Standaert DG, Bauer DC, Greenspan SL, Beck JC, Lyles KW. PMID: 33649343; PMCID: PMC7921548.
      View in: PubMed   Mentions: 5  
    51. Therapeutic Advances in Movement Disorders. Neurotherapeutics. 2020 10; 17(4):1325-1330. Tanner CM, Ostrem JL. PMID: 33452629; PMCID: PMC7810426.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    52. Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD). Ann Clin Transl Neurol. 2021 02; 8(2):308-320. Schneider RB, Omberg L, Macklin EA, Daeschler M, Bataille L, Anthwal S, Myers TL, Baloga E, Duquette S, Snyder P, Amodeo K, Tarolli CG, Adams JL, Callahan KF, Gottesman J, Kopil CM, Lungu C, Ascherio A, Beck JC, Biglan K, Espay AJ, Tanner C, Oakes D, Shoulson I, Novak D, Kayson E, Ray Dorsey E, Mangravite L, Schwarzschild MA, Simuni T, Parkinson Study Group AT-HOME PD Investigators. PMID: 33350601; PMCID: PMC7886038.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    53. Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder. Ann Clin Transl Neurol. 2021 01; 8(1):201-212. Chahine LM, Brumm MC, Caspell-Garcia C, Oertel W, Mollenhauer B, Amara A, Fernandez-Arcos A, Tolosa E, Simonet C, Hogl B, Videnovic A, Hutten SJ, Tanner C, Weintraub D, Burghardt E, Coffey C, Cho HR, Kieburtz K, Poston KL, Merchant K, Galasko D, Foroud T, Siderowf A, Marek K, Simuni T, Iranzo A. PMID: 33321002; PMCID: PMC7818144.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    54. Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice. CNS Spectr. 2022 04; 27(2):208-217. Hauser RA, Meyer JM, Factor SA, Comella CL, Tanner CM, Xavier RM, Caroff SN, Lundt L. PMID: 33213556; PMCID: PMC9249122.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    55. Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP). Front Aging Neurosci. 2020; 12:553635. Sturchio A, Marsili L, Vizcarra JA, Dwivedi AK, Kauffman MA, Duker AP, Lu P, Pauciulo MW, Wissel BD, Hill EJ, Stecher B, Keeling EG, Vagal AS, Wang L, Haslam DB, Robson MJ, Tanner CM, Hagey DW, El Andaloussi S, Ezzat K, Fleming RMT, Lu LJ, Little MA, Espay AJ. PMID: 33132895; PMCID: PMC7578373.
      View in: PubMed   Mentions: 8  
    56. Exploring the clinical burden of OFF periods in Parkinson disease. Am J Manag Care. 2020 10; 26(12 Suppl):S255-S264. Tanner CM. PMID: 33058688.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    57. The economic impact of OFF periods in Parkinson disease. Am J Manag Care. 2020 10; 26(12 Suppl):S265-S269. Abeynayake I, Tanner CM. PMID: 33058689.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    58. The Impact of COVID-19 on Access to Parkinson's Disease Medication. Mov Disord. 2020 12; 35(12):2129-2133. Cheong JL, Goh ZHK, Marras C, Tanner CM, Kasten M, Noyce AJ, Movement Disorders Society Epidemiology Study Group. PMID: 32860226.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    59. Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression. Mov Disord. 2020 11; 35(11):1999-2008. Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H, Schade S, Gera RG, Wang W, Gao F, Frasier M, Chahine LM, Coffey CS, Singleton AB, Simuni T, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Marek K, Siderowf A, Cedarbaum JM, Hutten SJ, Trenkwalder C, Graham D. PMID: 32798333; PMCID: PMC8017468.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    60. Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance. Mov Disord. 2020 10; 35(10):1755-1764. San Luciano M, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE, Tolosa E, Schüle B, Langston JW, Brice A, Corvol JC, Goldwurm S, Klein C, Brockman S, Berg D, Brockmann K, Ferreira JJ, Tazir M, Mellick GD, Sue CM, Hasegawa K, Tan EK, Bressman S, Saunders-Pullman R, Michael J. Fox Foundation LRRK2 Cohort Consortium. PMID: 32662532; PMCID: PMC7572560.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    61. Current and projected future economic burden of Parkinson's disease in the U.S. NPJ Parkinsons Dis. 2020; 6:15. Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, Ray Dorsey E, Dahodwala N, Cintina I, Hogan P, Thompson T. PMID: 32665974; PMCID: PMC7347582.
      View in: PubMed   Mentions: 152  
    62. Electrocardiographic changes predate Parkinson's disease onset. Sci Rep. 2020 07 09; 10(1):11319. Akbilgic O, Kamaleswaran R, Mohammed A, Ross GW, Masaki K, Petrovitch H, Tanner CM, Davis RL, Goldman SM. PMID: 32647196; PMCID: PMC7347531.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    63. Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease. Ann Neurol. 2020 09; 88(3):574-587. Irwin DJ, Fedler J, Coffey CS, Caspell-Garcia C, Kang JH, Simuni T, Foroud T, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Weintraub D, Mollenhauer B, Galasko DR, Siderowf A, Marek K, Trojanowski JQ, Shaw LM, Parkinson's Progression Marker Initiative. PMID: 32542885; PMCID: PMC7497251.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    64. Remote telemedicine evaluation of deep brain stimulation candidacy: Retrospective cohort analysis. Neurol Clin Pract. 2020 Jun; 10(3):199-205. Witek N, Heath SL, Ouyang B, Tanner CM, Galifianakis NB. PMID: 32642321; PMCID: PMC7292554.
      View in: PubMed   Mentions: 8  
    65. Reply to: Diagnostic Delay in Cervical Dystonia-Dystonia With Antecedent ET? Mov Disord. 2020 06; 35(6):1086-1087. LaHue SC, Tanner CM. PMID: 32562459.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings. J Clin Psychopharmacol. 2020 May/Jun; 40(3):259-268. Caroff SN, Yeomans K, Lenderking WR, Cutler AJ, Tanner CM, Shalhoub H, Pagé V, Chen J, Franey E, Yonan C. PMID: 32332461; PMCID: PMC7190052.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    67. Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson's disease. Sci Data. 2020 02 24; 7(1):67. Smolensky L, Amondikar N, Crawford K, Neu S, Kopil CM, Daeschler M, Riley L, 23andMe Research Team, Brown E, Toga AW, Tanner C. PMID: 32094335; PMCID: PMC7039948.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansPHPublic Health
    68. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study. Mov Disord. 2020 05; 35(5):833-844. Simuni T, Brumm MC, Uribe L, Caspell-Garcia C, Coffey CS, Siderowf A, Alcalay RN, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Nudelman K, Tosun-Turgut D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Bressman S, Marek K, Parkinson's Progression Markers Initiative Investigators. PMID: 32073681; PMCID: PMC7231646.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    69. β-adrenoreceptors and the risk of Parkinson's disease. Lancet Neurol. 2020 03; 19(3):247-254. Hopfner F, Höglinger GU, Kuhlenbäumer G, Pottegård A, Wod M, Christensen K, Tanner CM, Deuschl G. PMID: 31999942.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    70. EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease. J Parkinsons Dis. 2020; 10(2):543-558. Tanner CM, Pahwa R, Hauser RA, Oertel WH, Isaacson SH, Jankovic J, Johnson R, Chernick D, Hubble J. PMID: 31929122; PMCID: PMC7242830.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    71. Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person. J Parkinsons Dis. 2020; 10(2):677-691. Chahine LM, Chin I, Caspell-Garcia C, Standaert DG, Brown E, Smolensky L, Arnedo V, Daeschler D, Riley L, Korell M, Dobkin R, Amondikar N, Gradinscak S, Shoulson I, Dean M, Kwok K, Cannon P, Marek K, Kopil C, Tanner CM, Marras C, Fox Insight Study. PMID: 31958097; PMCID: PMC7242834.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    72. Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience. J Parkinsons Dis. 2020; 10(2):665-675. Dobkin RD, Amondikar N, Kopil C, Caspell-Garcia C, Brown E, Chahine LM, Marras C, Dahodwala N, Mantri S, Standaert DG, Dean M, Shoulson I, Marek K, Katz A, Korell M, Riley L, Tanner CM, Fox Insight Study. PMID: 32250321; PMCID: PMC7242847.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    73. A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design. J Parkinsons Dis. 2020; 10(3):1195-1207. Schneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson R, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Cannon P, 23andMe Research Team, Holloway RG, Dorsey ER. PMID: 32568109; PMCID: PMC7505001.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    74. Translation, Validation, Diagnostic Accuracy, and Reliability of Screening Questionnaire for Parkinsonism in Three African Countries. J Parkinsons Dis. 2020; 10(3):1113-1122. Shalash A, Okubadejo NU, Doumbe J, Ojo OO, Hamid E, Kuate C, Calvo S, Helmi A, Agabi OP, Essam M, Aguado L, Elrassas H, Roushdy T, Tanner CM, Cubo E. PMID: 32568112.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. The Effect of the COVID-19 Pandemic on People with Parkinson's Disease. J Parkinsons Dis. 2020; 10(4):1365-1377. Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, Arnedo V, Marek KL, Tanner CM. PMID: 32925107; PMCID: PMC7683050.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansPHPublic Health
    76. Cervical dystonia incidence and diagnostic delay in a multiethnic population. Mov Disord. 2020 03; 35(3):450-456. LaHue SC, Albers K, Goldman S, Lo RY, Gu Z, Leimpeter A, Fross R, Comyns K, Marras C, de Kleijn A, Smit R, Katz M, Ozelius LJ, Bressman S, Saunders-Pullman R, Comella C, Klingman J, Nelson LM, Van Den Eeden SK, Tanner CM. PMID: 31774238; PMCID: PMC10683845.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    77. A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia. J Clin Psychopharmacol. 2019 Nov/Dec; 39(6):620-627. Marder SR, Singer C, Lindenmayer JP, Tanner CM, Comella CL, Verghese C, Jimenez R, Liang GS, Burke J, O'Brien CF. PMID: 31688452.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    78. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. Lancet Neurol. 2020 01; 19(1):71-80. Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten SJ, Bressman S, Marek K, PPMI Investigators. PMID: 31678032; PMCID: PMC6956652.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    79. Excessive daytime sleepiness and topographic expansion of Lewy pathology. Neurology. 2019 10 08; 93(15):e1425-e1432. Abbott RD, Ross GW, Duda JE, Shin C, Uyehara-Lock JH, Masaki KH, Launer LJ, White LR, Tanner CM, Petrovitch H. PMID: 31471503; PMCID: PMC7010324.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    80. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med. 2020 02; 36(1):1-12. Simon DK, Tanner CM, Brundin P. PMID: 31733690; PMCID: PMC6905381.
      View in: PubMed   Mentions: 245     Fields:    Translation:Humans
    81. Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease. Mov Disord. 2019 09; 34(9):1354-1364. Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Singleton A, Shaw LM, Trojanowski JQ, Frasier M, Simuni T, Iranzo A, Oertel W, Siderowf A, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Marek K, Galasko D, PPMI study. PMID: 31361367; PMCID: PMC7098385.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    82. The NAS-NRC Twin Registry and Duke Twins Study of Memory in Aging: An Update. Twin Res Hum Genet. 2019 12; 22(6):757-760. Gatz M, Plassman BL, Tanner CM, Goldman SM, Swan GE, Chanti-Ketterl M, Walters EE, Butler DA. PMID: 31354124; PMCID: PMC7048234.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    83. Rotenone and Parkinson's Disease: Reduced Sensitivity in Females. Toxicol Sci. 2019 06 01; 170(2):562-563. Goldman SM, Tanner CM. PMID: 31161209.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    84. A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease. Proc Natl Acad Sci U S A. 2019 04 09; 116(15):7419-7424. Hollenbach JA, Norman PJ, Creary LE, Damotte V, Montero-Martin G, Caillier S, Anderson KM, Misra MK, Nemat-Gorgani N, Osoegawa K, Santaniello A, Renschen A, Marin WM, Dandekar R, Parham P, Tanner CM, Hauser SL, Fernandez-Viña M, Oksenberg JR. PMID: 30910980; PMCID: PMC6462083.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsCTClinical Trials
    85. Concordance for Parkinson's disease in twins: A 20-year update. Ann Neurol. 2019 04; 85(4):600-605. Goldman SM, Marek K, Ottman R, Meng C, Comyns K, Chan P, Ma J, Marras C, Langston JW, Ross GW, Tanner CM. PMID: 30786044.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    86. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 2019 02 12; 92(7):329-337. Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, Litvan I, Mata IF, Zabetian CP, Brundin P, Fernandez HH, Standaert DG, Kauffman MA, Schwarzschild MA, Sardi SP, Sherer T, Perry G, Leverenz JB. PMID: 30745444; PMCID: PMC6382364.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    87. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI). Parkinsonism Relat Disord. 2019 05; 62:201-209. Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, Arnedo V, Frasier M, Sherer T, Marek K, Frank S, Jennings D, Simuni T, Parkinson's Progression Markers InitiativeSteering Committee, Study Cores, Site Investigators, Coordinators, Industry and Scientific Advisory Board. PMID: 30738748; PMCID: PMC8978879.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    88. Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures. J Parkinsons Dis. 2019; 9(4):665-679. Chahine LM, Siderowf A, Barnes J, Seedorff N, Caspell-Garcia C, Simuni T, Coffey CS, Galasko D, Mollenhauer B, Arnedo V, Daegele N, Frasier M, Tanner C, Kieburtz K, Marek K, The Parkinson’s Progression Markers Initiative. PMID: 31450510; PMCID: PMC6839498.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    89. Association of brain heptachlor epoxide and other organochlorine compounds with lewy pathology. Mov Disord. 2019 02; 34(2):228-235. Ross GW, Abbott RD, Petrovitch H, Duda JE, Tanner CM, Zarow C, Uyehara-Lock JH, Masaki KH, Launer LJ, Studabaker WB, White LR. PMID: 30597605; PMCID: PMC6602549.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    90. Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes". Parkinsonism Relat Disord. 2019 09; 66:245-246. Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C. PMID: 30655161.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    91. The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort. Ann Clin Transl Neurol. 2018 Dec; 5(12):1460-1477. Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T, Parkinson's Progression Markers Initiative. PMID: 30564614; PMCID: PMC6292383.
      View in: PubMed   Mentions: 157     Fields:    
    92. Occupational exposures and parkinsonism among Shanghai women textile workers. Am J Ind Med. 2018 11; 61(11):886-892. Checkoway H, Ilango S, Li W, Ray RM, Tanner CM, Hu SC, Wang X, Nielsen S, Gao DL, Thomas DB. PMID: 30198067.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsPHPublic Health
    93. Mendel and urate: Acid test or random noise? Parkinsonism Relat Disord. 2018 08; 53:1-3. Brown EG, Goldman SM, Tanner CM. PMID: 30100365.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    94. Reproducibility of data-driven Parkinson's disease subtypes for clinical research. Parkinsonism Relat Disord. 2018 11; 56:102-106. Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C. PMID: 30056038.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    95. Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort. Mov Disord. 2018 05; 33(5):771-782. Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun D, Poston K, Arnedo V, Frasier M, Sherer T, Chowdhury S, Marek K, Parkinson's Progression Marker Initiative*. PMID: 29572948; PMCID: PMC6001458.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    96. Telemedicine Use for Movement Disorders: A Global Survey. Telemed J E Health. 2018 12; 24(12):979-992. Hassan A, Dorsey ER, Goetz CG, Bloem BR, Guttman M, Tanner CM, Mari Z, Pantelyat A, Galifianakis NB, Bajwa JA, Gatto EM, Cubo E. PMID: 29565764.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    97. Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open-label ADS-5102. Mov Disord Clin Pract. 2018 Mar-Apr; 5(2):183-190. Isaacson SH, Fahn S, Pahwa R, Tanner CM, Espay AJ, Trenkwalder C, Adler CH, Patni R, Johnson R. PMID: 29780852; PMCID: PMC5947645.
      View in: PubMed   Mentions: 6  
    98. Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease. Mov Disord. 2018 03; 33(3):472-478. Tanner C, Marder K, Eberly S, Biglan K, Oakes D, Shoulson I, Huntington Study Group Prospective Huntington At-Risk Observational Study Investigators. PMID: 29297592; PMCID: PMC5986294.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    99. Impaired Cognition and the Risk of Parkinson Disease: Trouble in Mind. JAMA Neurol. 2017 12 01; 74(12):1398-1400. Brown EG, Tanner CM. PMID: 28973080.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    100. Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort. J Neurol Neurosurg Psychiatry. 2018 01; 89(1):78-88. Simuni T, Caspell-Garcia C, Coffey CS, Weintraub D, Mollenhauer B, Lasch S, Tanner CM, Jennings D, Kieburtz K, Chahine LM, Marek K. PMID: 28986467; PMCID: PMC5732865.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    101. Lessons Learned From Past Gene-Environment Interaction Successes. Am J Epidemiol. 2017 Oct 01; 186(7):778-786. Ritz BR, Chatterjee N, Garcia-Closas M, Gauderman WJ, Pierce BL, Kraft P, Tanner CM, Mechanic LE, McAllister K. PMID: 28978190; PMCID: PMC5860326.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    102. Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3). Mov Disord. 2017 Dec; 32(12):1701-1709. Oertel W, Eggert K, Pahwa R, Tanner CM, Hauser RA, Trenkwalder C, Ehret R, Azulay JP, Isaacson S, Felt L, Stempien MJ. PMID: 28833562; PMCID: PMC5763269.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    103. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017 Sep 12; 89(11):1152-1161. Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Aldred J, Carter J, Fraser A, Jimenez-Shahed J, Hunter C, Spindler M, Reichwein S, Mari Z, Dunlop B, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Mejia NI, Bwala G, Nance M, Shih LC, Singer C, Vargas-Parra S, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Dhall R, Hassan A, DeMello S, Riggare SS, Wicks P, Achey MA, Elson MJ, Goldenthal S, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W, Connect.Parkinson Investigators. PMID: 28814455; PMCID: PMC5595275.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    104. ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial. JAMA Neurol. 2017 08 01; 74(8):941-949. Pahwa R, Tanner CM, Hauser RA, Isaacson SH, Nausieda PA, Truong DD, Agarwal P, Hull KL, Lyons KE, Johnson R, Stempien MJ. PMID: 28604926; PMCID: PMC5710325.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCTClinical Trials
    105. Virtual visits for Parkinson disease: A multicenter noncontrolled cohort. Neurol Clin Pract. 2017 08; 7(4):283-295. Korn RE, Wagle Shukla A, Katz M, Keenan HT, Goldenthal S, Auinger P, Zhu W, Dodge M, Rizer K, Achey MA, Byrd E, Barbano R, Richard I, Andrzejewski KL, Schwarz HB, Dorsey ER, Biglan KM, Kang G, Kanchana S, Rodriguez R, Tanner CM, Galifianakis NB. PMID: 28840919; PMCID: PMC5566796.
      View in: PubMed   Mentions: 20  
    106. Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. Lancet Neurol. 2017 08; 16(8):620-629. Liu G, Locascio JJ, Corvol JC, Boot B, Liao Z, Page K, Franco D, Burke K, Jansen IE, Trisini-Lipsanopoulos A, Winder-Rhodes S, Tanner CM, Lang AE, Eberly S, Elbaz A, Brice A, Mangone G, Ravina B, Shoulson I, Cormier-Dequaire F, Heutink P, van Hilten JJ, Barker RA, Williams-Gray CH, Marinus J, Scherzer CR, HBS, CamPaIGN, PICNICS, PROPARK, PSG, DIGPD, PDBP. PMID: 28629879; PMCID: PMC5761650.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    107. A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease. PLoS One. 2017; 12(6):e0178982. Hayete B, Wuest D, Laramie J, McDonagh P, Church B, Eberly S, Lang A, Marek K, Runge K, Shoulson I, Singleton A, Tanner C, Khalil I, Verma A, Ravina B. PMID: 28604798; PMCID: PMC5467836.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    108. Parkinson disease. Nat Rev Dis Primers. 2017 Mar 23; 3:17013. Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE. PMID: 28332488.
      View in: PubMed   Mentions: 1557     Fields:    Translation:HumansCells
    109. Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials. Mov Disord. 2017 03; 32(3):319-324. Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, Lang AE. PMID: 28233927; PMCID: PMC5359057.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    110. Caffeine, creatine, GRIN2A and Parkinson's disease progression. J Neurol Sci. 2017 Apr 15; 375:355-359. Simon DK, Wu C, Tilley BC, Lohmann K, Klein C, Payami H, Wills AM, Aminoff MJ, Bainbridge J, Dewey R, Hauser RA, Schaake S, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wei P, Wong PS, Yang T. PMID: 28320167; PMCID: PMC5386398.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    111. Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease. Mov Disord. 2017 04; 32(4):610-614. Visanji NP, Bhudhikanok GS, Mestre TA, Ghate T, Udupa K, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kim S, Azhu Valappil R, Kausar F, Rogaeva E, William Langston J, Tanner CM, Schüle B, Lang AE, Goldman SM, Marras C. PMID: 28071824.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    112. ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study. J Parkinsons Dis. 2017; 7(3):511-522. Hauser RA, Pahwa R, Tanner CM, Oertel W, Isaacson SH, Johnson R, Felt L, Stempien MJ. PMID: 28777755; PMCID: PMC5611804.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    113. Knowledge gaps and research recommendations for essential tremor. Parkinsonism Relat Disord. 2016 12; 33:27-35. Hopfner F, Haubenberger D, Galpern WR, Gwinn K, Van't Veer A, White S, Bhatia K, Adler CH, Eidelberg D, Ondo W, Stebbins GT, Tanner CM, Helmich RC, Lenz FA, Sillitoe RV, Vaillancourt D, Vitek JL, Louis ED, Shill HA, Frosch MP, Foroud T, Kuhlenbäumer G, Singleton A, Testa CM, Hallett M, Elble R, Deuschl G. PMID: 27769649; PMCID: PMC5271603.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    114. The best medicine? The influence of physical activity and inactivity on Parkinson's disease. Mov Disord. 2016 10; 31(10):1444-1454. LaHue SC, Comella CL, Tanner CM. PMID: 27477046; PMCID: PMC9491025.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    115. Role of Neuroinflammation in Parkinson Disease: The Enigma Continues. Mayo Clin Proc. 2016 10; 91(10):1328-1330. Mehta SH, Tanner CM. PMID: 27712631.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    116. Problematic Mobile Gaming in Parkinson's Disease: An Impulse Control Disorder for the Smartphone. Mov Disord Clin Pract. 2017 Mar-Apr; 4(2):277-278. Galifianakis NB, Byrd EA, Ostrem JL, Tanner CM, Racine CA. PMID: 30838269; PMCID: PMC6353464.
      View in: PubMed   Mentions: 2  
    117. Predictors of time to initiation of symptomatic therapy in early Parkinson's disease. Ann Clin Transl Neurol. 2016 Jul; 3(7):482-94. Simuni T, Long JD, Caspell-Garcia C, Coffey CS, Lasch S, Tanner CM, Jennings D, Kieburtz KD, Marek K, PPMI Investigators. PMID: 27386498; PMCID: PMC4931714.
      View in: PubMed   Mentions: 14     Fields:    
    118. How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort? Parkinsonism Relat Disord. 2016 07; 28:62-7. Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Tanner C, Marek K, PPMI Investigators. PMID: 27132498.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    119. CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study. Acta Neuropathol. 2016 06; 131(6):935-49. Kang JH, Mollenhauer B, Coffey CS, Toledo JB, Weintraub D, Galasko DR, Irwin DJ, Van Deerlin V, Chen-Plotkin AS, Caspell-Garcia C, Waligórska T, Taylor P, Shah N, Pan S, Zero P, Frasier M, Marek K, Kieburtz K, Jennings D, Tanner CM, Simuni T, Singleton A, Toga AW, Chowdhury S, Trojanowski JQ, Shaw LM, Parkinson’s Progression Marker Initiative. PMID: 27021906; PMCID: PMC5031365.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    120. National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers. Telemed J E Health. 2016 07; 22(7):590-8. Dorsey ER, Achey MA, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Ziman N, Aldred J, Carter J, Jimenez-Shahed J, Hunter C, Spindler M, Mari Z, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Bull MT, Mejia NI, Bwala G, Nance M, Shih L, Anderson L, Singer C, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Cooper J, Webb S, Dhall R, Hassan A, Weis D, DeMello S, Riggare SS, Wicks P, Smith J, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W. PMID: 26886406; PMCID: PMC4939367.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    121. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. JAMA Neurol. 2016 Jan; 73(1):102-10. Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C. PMID: 26569098.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    122. Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's Disease. Mov Disord Clin Pract. 2016 Jan-Feb; 3(1):53-58. Kurlan R, Ravina B, Eberly S, Lang AE, Tanner CM, Marek K, Marder K, Beck J, Elliott R, Oakes D, Shoulson I, PSG PostCEPT (LABS-PD) Investigators. PMID: 30363507; PMCID: PMC6178710.
      View in: PubMed   Mentions:
    123. Midlife milk consumption and substantia nigra neuron density at death. Neurology. 2016 Feb 09; 86(6):512-9. Abbott RD, Ross GW, Petrovitch H, Masaki KH, Launer LJ, Nelson JS, White LR, Tanner CM. PMID: 26658906; PMCID: PMC4753730.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    124. Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. Clin Neuropharmacol. 2015 Sep-Oct; 38(5):163-9. Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS. PMID: 26366971; PMCID: PMC4573899.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    125. Parkinson's disease research in a prospective cohort in China. Parkinsonism Relat Disord. 2015 Oct; 21(10):1200-4. Chen H, Ding D, Wang J, Zhao Q, Meng H, Li H, Gao YT, Shu XO, Tanner CM, Hong Z, Yang G. PMID: 26318964; PMCID: PMC4587359.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    126. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits. Mov Disord. 2015 Dec; 30(14):1885-92. Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, Berg D, Wurster I, Gauss K, Sprenger F, Seppi K, Poewe W, Mollenhauer B, Knake S, Mari Z, McCoy A, Ranola M, Marek K. PMID: 26260437.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    127. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California. Sleep. 2015 Jul 01; 38(7):1009-15. Van Den Eeden SK, Albers KB, Davidson JE, Kushida CA, Leimpeter AD, Nelson LM, Popat R, Tanner CM, Bibeau K, Quesenberry CP. PMID: 26083613; PMCID: PMC4481004.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    128. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015 Jul; 14(7):710-9. Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J. PMID: 26025783; PMCID: PMC4472464.
      View in: PubMed   Mentions: 144     Fields:    Translation:Humans
    129. Associations of Ozone and PM2.5 Concentrations With Parkinson's Disease Among Participants in the Agricultural Health Study. J Occup Environ Med. 2015 May; 57(5):509-17. Kirrane EF, Bowman C, Davis JA, Hoppin JA, Blair A, Chen H, Patel MM, Sandler DP, Tanner CM, Vinikoor-Imler L, Ward MH, Luben TJ, Kamel F. PMID: 25951420; PMCID: PMC4428683.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    130. Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol. 2015 Jun; 77(6):987-95. Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM, Yaffe K. PMID: 25726936; PMCID: PMC4447556.
      View in: PubMed   Mentions: 126     Fields:    Translation:Humans
    131. Variants associated with Gaucher disease in multiple system atrophy. Ann Clin Transl Neurol. 2015 Apr; 2(4):417-26. Mitsui J, Matsukawa T, Sasaki H, Yabe I, Matsushima M, Dürr A, Brice A, Takashima H, Kikuchi A, Aoki M, Ishiura H, Yasuda T, Date H, Ahsan B, Iwata A, Goto J, Ichikawa Y, Nakahara Y, Momose Y, Takahashi Y, Hara K, Kakita A, Yamada M, Takahashi H, Onodera O, Nishizawa M, Watanabe H, Ito M, Sobue G, Ishikawa K, Mizusawa H, Kanai K, Hattori T, Kuwabara S, Arai K, Koyano S, Kuroiwa Y, Hasegawa K, Yuasa T, Yasui K, Nakashima K, Ito H, Izumi Y, Kaji R, Kato T, Kusunoki S, Osaki Y, Horiuchi M, Kondo T, Murayama S, Hattori N, Yamamoto M, Murata M, Satake W, Toda T, Filla A, Klockgether T, Wüllner U, Nicholson G, Gilman S, Tanner CM, Kukull WA, Stern MB, Lee VM, Trojanowski JQ, Masliah E, Low PA, Sandroni P, Ozelius LJ, Foroud T, Tsuji S. PMID: 25909086; PMCID: PMC4402086.
      View in: PubMed   Mentions: 54     Fields:    
    132. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA. 2015 Feb 10; 313(6):584-93. Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators, Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, Cines M, Dahodwala N, Derwent L, Dewey RB, Hawthorne K, Houghton DJ, Kamp C, Leehey M, Lew MF, Liang GS, Luo ST, Mari Z, Morgan JC, Parashos S, Pérez A, Petrovitch H, Rajan S, Reichwein S, Roth JT, Schneider JS, Shannon KM, Simon DK, Simuni T, Singer C, Sudarsky L, Tanner CM, Umeh CC, Williams K, Wills AM. PMID: 25668262; PMCID: PMC4349346.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    133. Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study). Mov Disord. 2015 May; 30(6):788-95. Pahwa R, Tanner CM, Hauser RA, Sethi K, Isaacson S, Truong D, Struck L, Ruby AE, McClure NL, Went GT, Stempien MJ. PMID: 25650051; PMCID: PMC5024015.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    134. When brawn benefits brain: physical activity and Parkinson's disease risk. Brain. 2015 Feb; 138(Pt 2):238-9. Tanner CM, Comella CL. PMID: 25627233; PMCID: PMC4394643.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    135. Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease. Environ Int. 2015 Feb; 75:144-50. Furlong M, Tanner CM, Goldman SM, Bhudhikanok GS, Blair A, Chade A, Comyns K, Hoppin JA, Kasten M, Korell M, Langston JW, Marras C, Meng C, Richards M, Ross GW, Umbach DM, Sandler DP, Kamel F. PMID: 25461423; PMCID: PMC4272866.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansPHPublic Health
    136. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study. Mov Disord. 2015 Feb; 30(2):278-83. Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, Cote L, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Payami H, Molho E, Factor SA, Nutt J, Serrano C, Arroyo M, Pauciulo MW, Nichols WC, Clark LN, Alcalay RN, Marder KS. PMID: 25393808; PMCID: PMC4318772.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    137. Mendelian randomization of serum urate and parkinson disease progression. Ann Neurol. 2014 Dec; 76(6):862-8. Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A, Parkinson Study Group. PMID: 25257975; PMCID: PMC4245314.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    138. Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants. Genet Med. 2014 Aug; 16(8):644-5. Alcalay RN, Aasly J, Berg D, Bressman S, Brice A, Brockmann K, Chan P, Clark L, Cormier F, Corvol JC, Durr A, Facheris M, Farrer M, Foroud TM, Gasser T, Giladi N, Halter C, Lang A, Langston JW, Marras C, Marti-Masso JF, Ruiz Martinez J, Mejia-Santana H, Mirelman A, Pont-Sunyer C, Orr-Urtreger A, Raymond D, Saunders-Pullman R, Schüle B, Tanner C, Tolosa E, Urkowitz A, Vilas D, Wise A, Marder K. PMID: 25093570; PMCID: PMC4682659.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    139. The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk. Alzheimers Dement. 2014 Jun; 10(3 Suppl):S213-25. Tanner CM, Goldman SM, Ross GW, Grate SJ. PMID: 24924672.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsPHPublic Health
    140. The past, present, and future of telemedicine for Parkinson's disease. Mov Disord. 2014 Jun; 29(7):871-83. Achey M, Aldred JL, Aljehani N, Bloem BR, Biglan KM, Chan P, Cubo E, Dorsey ER, Goetz CG, Guttman M, Hassan A, Khandhar SM, Mari Z, Spindler M, Tanner CM, van den Haak P, Walker R, Wilkinson JR, International Parkinson and Movement Disorder Society Telemedicine Task Force. PMID: 24838316.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    141. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Mov Disord. 2014 Aug; 29(9):1171-80. Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Sandler DP, Langston JW, Tanner CM. PMID: 24838182; PMCID: PMC4777298.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    142. A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study. Mov Disord. 2014 May; 29(6):743-9. Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, DiEuliis D, Fahn S, Elliott RA, Shoulson I. PMID: 24515275; PMCID: PMC5656448.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    143. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. JAMA Neurol. 2014 Jan; 71(1):62-7. Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak KE, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Payami H, Molho E, Factor SA, Nutt JG, Serrano C, Arroyo M, Ottman R, Pauciulo MW, Nichols WC, Clark LN, Marder KS. PMID: 24190026; PMCID: PMC3947132.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    144. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol. 2013 Nov; 70(11):1382-8. Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, Shoulson I, Huntington Study Group PHAROS Investigators. PMID: 24000094; PMCID: PMC4040231.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    145. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments. Mov Disord. 2013 Dec; 28(14):1980-6. Lang AE, Eberly S, Goetz CG, Stebbins G, Oakes D, Marek K, Ravina B, Tanner CM, Shoulson I, LABS-PD investigators. PMID: 24123383.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    146. Dietary fat intake, pesticide use, and Parkinson's disease. Parkinsonism Relat Disord. 2014 Jan; 20(1):82-7. Kamel F, Goldman SM, Umbach DM, Chen H, Richardson G, Barber MR, Meng C, Marras C, Korell M, Kasten M, Hoppin JA, Comyns K, Chade A, Blair A, Bhudhikanok GS, Webster Ross G, William Langston J, Sandler DP, Tanner CM. PMID: 24120951; PMCID: PMC3936597.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    147. Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurol. 2013 Oct; 70(10):1277-87. Kang JH, Irwin DJ, Chen-Plotkin AS, Siderowf A, Caspell C, Coffey CS, Waligórska T, Taylor P, Pan S, Frasier M, Marek K, Kieburtz K, Jennings D, Simuni T, Tanner CM, Singleton A, Toga AW, Chowdhury S, Mollenhauer B, Trojanowski JQ, Shaw LM, Parkinson's Progression Markers Initiative. PMID: 23979011; PMCID: PMC4034348.
      View in: PubMed   Mentions: 219     Fields:    Translation:HumansCells
    148. Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications. Environ Health Perspect. 2013 Nov-Dec; 121(11-12):1245-52. Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbott RD, Ascherio A, Caviness JN, Gao X, Gray KA, Hong JS, Kamel F, Jennings D, Kirshner A, Lawler C, Liu R, Miller GW, Nussbaum R, Peddada SD, Rick AC, Ritz B, Siderowf AD, Tanner CM, Tröster AI, Zhang J. PMID: 23933572; PMCID: PMC3855519.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    149. Alpha-synuclein: one key opens many locks. Mov Disord. 2013 Aug; 28(9):1176-8. Tanner CM. PMID: 23925937.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    150. A second honeymoon for Parkinson's disease? N Engl J Med. 2013 Feb 14; 368(7):675-6. Tanner CM. PMID: 23406033.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    151. Which dyskinesia scale best detects treatment response? Mov Disord. 2013 Mar; 28(3):341-6. Goetz CG, Stebbins GT, Chung KA, Hauser RA, Miyasaki JM, Nicholas AP, Poewe W, Seppi K, Rascol O, Stacy MA, Nutt JG, Tanner CM, Urkowitz A, Jaglin JA, Ge S. PMID: 23390076.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    152. Caffeine consumption and risk of dyskinesia in CALM-PD. Mov Disord. 2013 Mar; 28(3):380-3. Wills AM, Eberly S, Tennis M, Lang AE, Messing S, Togasaki D, Tanner CM, Kamp C, Chen JF, Oakes D, McDermott MP, Schwarzschild MA, Parkinson Study Group. PMID: 23339054; PMCID: PMC3608707.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    153. Linked clinical trials--the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments. J Parkinsons Dis. 2013 Jan 01; 3(3):231-9. Brundin P, Barker RA, Conn PJ, Dawson TM, Kieburtz K, Lees AJ, Schwarzschild MA, Tanner CM, Isaacs T, Duffen J, Matthews H, Wyse RK. PMID: 24018336; PMCID: PMC4318242.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    154. Genetic modification of the association of paraquat and Parkinson's disease. Mov Disord. 2012 Nov; 27(13):1652-8. Goldman SM, Kamel F, Ross GW, Bhudhikanok GS, Hoppin JA, Korell M, Marras C, Meng C, Umbach DM, Kasten M, Chade AR, Comyns K, Richards MB, Sandler DP, Blair A, Langston JW, Tanner CM. PMID: 23045187; PMCID: PMC3572192.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansPHPublic Health
    155. Brain organochlorines and Lewy pathology: the Honolulu-Asia Aging Study. Mov Disord. 2012 Sep 15; 27(11):1418-24. Ross GW, Duda JE, Abbott RD, Pellizzari E, Petrovitch H, Miller DB, O'Callaghan JP, Tanner CM, Noorigian JV, Masaki K, Launer L, White LR. PMID: 22976848; PMCID: PMC3474594.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    156. Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease. Mov Disord. 2012 Sep 15; 27(11):1392-7. Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, Beal F, Beck J, Flagg E, Galpern WR, Harman J, Lang AE, Schwarzschild M, Tanner C, Shoulson I. PMID: 22976926; PMCID: PMC5404810.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    157. Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. Parkinsonism Relat Disord. 2012 Sep; 18(8):958-63. Wang C, Cai Y, Zheng Z, Tang BS, Xu Y, Wang T, Ma J, Chen SD, Langston JW, Tanner CM, Chan P, Chinese Parkinson Study Group (CPSG). PMID: 22658533.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    158. A high-density genome-wide association screen of sporadic ALS in US veterans. PLoS One. 2012; 7(3):e32768. Kwee LC, Liu Y, Haynes C, Gibson JR, Stone A, Schichman SA, Kamel F, Nelson LM, Topol B, Van den Eeden SK, Tanner CM, Cudkowicz ME, Grasso DL, Lawson R, Muralidhar S, Oddone EZ, Schmidt S, Hauser MA. PMID: 22470424; PMCID: PMC3314660.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    159. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol. 2012 Mar; 71(3):370-84. Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T, PD GWAS Consortium. PMID: 22451204; PMCID: PMC3354734.
      View in: PubMed   Mentions: 151     Fields:    Translation:Humans
    160. Head injury, α-synuclein Rep1, and Parkinson's disease. Ann Neurol. 2012 Jan; 71(1):40-8. Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM. PMID: 22275250; PMCID: PMC3270814.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    161. Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. Parkinsonism Relat Disord. 2012 Jan; 18 Suppl 1:S199-202. Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR. PMID: 22166434.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    162. Solvent exposures and Parkinson disease risk in twins. Ann Neurol. 2012 Jun; 71(6):776-84. Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, Comyns K, Korell M, Chade AR, Kasten M, Priestley B, Chou KL, Fernandez HH, Cambi F, Langston JW, Tanner CM. PMID: 22083847; PMCID: PMC3366287.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansPHPublic Health
    163. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet. 2011 Jun; 7(6):e1002141. Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A, Eriksson N. PMID: 21738487; PMCID: PMC3121750.
      View in: PubMed   Mentions: 281     Fields:    Translation:Humans
    164. Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts. Mov Disord. 2011 Mar; 26(4):608-13. Marras C, McDermott MP, Marek K, Rochon P, Naglie G, Tanner CM, Rudolph A, Shoulson I, Lang AE, Parkinson Study Group DATATOP and PRECEPT investigators. PMID: 21287602.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    165. Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect. 2011 Jun; 119(6):866-72. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW. PMID: 21269927; PMCID: PMC3114824.
      View in: PubMed   Mentions: 498     Fields:    Translation:HumansCellsPHPublic Health
    166. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. J Int Neuropsychol Soc. 2011 Jan; 17(1):91-100. Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Cote LJ, Frucht S, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Siderowf AD, Ross BM, Verbitsky M, Kisselev S, Ottman R, Clark LN, Marder KS. PMID: 21092386; PMCID: PMC3366462.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    167. Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study. Mov Disord. 2010 Nov 15; 25(15):2587-94. Shino MY, McGuire V, Van Den Eeden SK, Tanner CM, Popat R, Leimpeter A, Bernstein AL, Nelson LM. PMID: 20842689; PMCID: PMC2978761.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    168. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. Mov Disord. 2010 Oct 30; 25(14):2296-303. Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, Goldman SM, Tanner CM, Langston JW. PMID: 20976736.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    169. Comorbid cancer in Parkinson's disease. Mov Disord. 2010 Sep 15; 25(12):1809-17. Lo RY, Tanner CM, Van Den Eeden SK, Albers KB, Leimpeter AD, Nelson LM. PMID: 20669266.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    170. Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease. Mov Disord. 2010 Sep 15; 25(12):1801-8. Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I, PSG PRECEPT Investigators, Shoulson I, Hyson C, Oakes D, Flagg E, Rudolph A, Kieburtz K, Lang A, Fahn S, Gauger L, Goetz C. PMID: 20669311.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    171. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol. 2010 Sep; 67(9):1116-22. Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, Verbitsky M, Kisselev S, Louis ED, Comella C, Colcher A, Jennings D, Nance MA, Bressman SB, Scott WK, Tanner C, Mickel S, Andrews H, Waters C, Fahn S, Cote L, Frucht S, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Ottman R, Marder K, Clark LN. PMID: 20837857; PMCID: PMC3329730.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    172. Late-life hemoglobin and the incidence of Parkinson's disease. Neurobiol Aging. 2012 May; 33(5):914-20. Abbott RD, Ross GW, Tanner CM, Andersen JK, Masaki KH, Rodriguez BL, White LR, Petrovitch H. PMID: 20709430; PMCID: PMC3006667.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    173. Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS). Mov Disord. 2010 Jul 15; 25(9):1190-4. Goetz CG, Stebbins GT, Chmura TA, Fahn S, Poewe W, Tanner CM. PMID: 20629138.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    174. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol. 2010 Jun; 67(6):731-8. Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Ross BM, Cote LJ, Frucht S, Ford B, Alcalay RN, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Neils GD, Verbitsky M, Kisselev S, Caccappolo E, Ottman R, Clark LN. PMID: 20558392; PMCID: PMC3329757.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    175. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. J Clin Exp Neuropsychol. 2010 Aug; 32(7):775-9. Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, Verbitsky M, Kisselev S, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, Mickel SF, Andrews HF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Ottman R, Clark LN, Marder KS, Caccappolo E. PMID: 20182943; PMCID: PMC2911493.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    176. Reliability and validity of two self-administered questionnaires for screening restless legs syndrome in population-based studies. Sleep Med. 2010 Feb; 11(2):154-60. Popat RA, Van Den Eeden SK, Tanner CM, Kushida CA, Rama AN, Black JE, Bernstein A, Kasten M, Chade A, Leimpeter A, Cassidy J, McGuire V, Nelson LM. PMID: 20089446.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    177. Advances in environmental epidemiology. Mov Disord. 2010; 25 Suppl 1:S58-62. Tanner CM. PMID: 20187243.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    178. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol. 2009 Dec; 66(12):1517-22. Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, Kisselev S, Ross BM, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, Mickel SF, Andrews HF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Caccappolo E, Ottman R, Clark LN, Marder KS. PMID: 20008657; PMCID: PMC2837584.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    179. Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol. 2009 Dec; 66(12):1460-8. Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, Oakes D, Fahn S, Shoulson I, Schwarzschild MA, Parkinson Study Group DATATOP Investigators. PMID: 19822770; PMCID: PMC2795011.
      View in: PubMed   Mentions: 148     Fields:    Translation:Humans
    180. Clinical features in early Parkinson disease and survival. Arch Neurol. 2009 Nov; 66(11):1353-8. Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, McGuire V, Quesenberry CP, Nelson LM, Van Den Eeden SK. PMID: 19901166.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    181. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Mov Disord. 2009 Oct 30; 24(14):2081-90. Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I, Parkinson Study Group LABS-PD Investigators. PMID: 19691116.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    182. Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol. 2009 Sep; 66(9):1106-13. Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, Bressman S, Deligtisch A, Marras C, Lyons KE, Bhudhikanok GS, Roucoux DF, Meng C, Abbott RD, Langston JW. PMID: 19752299.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansPHPublic Health
    183. Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord. 2009 Dec; 15(10):767-71. Qin Z, Zhang L, Sun F, Fang X, Meng C, Tanner C, Chan P, Chinese Parkinson Study Group. PMID: 19553154.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    184. Bowel movement frequency in late-life and substantia nigra neuron density at death. Mov Disord. 2009 Feb 15; 24(3):371-6. Petrovitch H, Abbott RD, Ross GW, Nelson J, Masaki KH, Tanner CM, Launer LJ, White LR. PMID: 19006191; PMCID: PMC3272050.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    185. Use of antihypertensives and the risk of Parkinson disease. Neurology. 2009 Feb 10; 72(6):578-9. Ascherio A, Tanner CM. PMID: 19204275.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    186. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg. 2008 Oct; 139(4):495-505. Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, Hallett M, Jinnah HA, Juergens U, Martin SB, Perlmutter JS, Sapienza C, Singleton A, Tanner CM, Woodson GE. PMID: 18922334; PMCID: PMC2643054.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    187. Nicotine and Parkinson's disease: implications for therapy. Mov Disord. 2008 Sep 15; 23(12):1641-52. Quik M, O'Leary K, Tanner CM. PMID: 18683238; PMCID: PMC4430096.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimals
    188. Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect. 2009 Jan; 117(1):117-21. Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, Duda J, English P, Goldman S, Grate S, Hansen J, Hoppin J, Jewell S, Kamel F, Koroshetz W, Langston JW, Logroscino G, Nelson L, Ravina B, Rocca W, Ross GW, Schettler T, Schwarzschild M, Scott B, Seegal R, Singleton A, Steenland K, Tanner CM, Van Den Eeden S, Weisskopf M. PMID: 19165397; PMCID: PMC2627854.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    189. Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial. Mov Disord. 2008 Apr 15; 23(5):653-9; quiz 776. Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE, Parkinson Study Group DATATOP Investigators. PMID: 18076084.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    190. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol. 2008 Feb; 63(2):167-73. Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR. PMID: 18067173.
      View in: PubMed   Mentions: 251     Fields:    Translation:HumansPHPublic Health
    191. Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord. 2007 Dec; 22(16):2371-7. May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, Marshall FJ, Wooten F, Shults CW, North American Multiple System Atrophy Study Group. PMID: 17914727.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    192. Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord. 2007 Aug 15; 22(11):1581-6. Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, Launer LJ, Curb JD, White LR. PMID: 17523195.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    193. Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007 Jun; 8(3):157-63. Popat RA, Tanner CM, van den Eeden SK, Bernstein AL, Bloch DA, Leimpeter A, McGuire V, Nelson LM. PMID: 17538777.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    194. G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Mov Disord. 2007 Mar 15; 22(4):546-9. Ozelius LJ, Foroud T, May S, Senthil G, Sandroni P, Low PA, Reich S, Colcher A, Stern MB, Ondo WG, Jankovic J, Huang N, Tanner CM, Novak P, Gilman S, Marshall FJ, Wooten GF, Chelimsky TC, Shults CW, North American Multiple System Atrophy Study Group. PMID: 17230458.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    195. Epidemiology of Parkinson's disease. Handb Clin Neurol. 2007; 83:129-51. Kasten M, Chade A, Tanner CM. PMID: 18808913; PMCID: PMC7112363.
      View in: PubMed   Mentions: 15     Fields:    
    196. Parkin gene variations and parkinsonism: association does not imply causation. Ann Neurol. 2007 Jan; 61(1):4-6. Langston JW, Tanner CM, Schüle B. PMID: 17262853.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    197. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord. 2006 Dec; 21(12):2062-7. Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, Markesbery WR, Hardman J, Masaki K, Launer L, White LR. PMID: 16991138.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    198. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol. 2006 Nov; 5(11):917-23. Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, Mellick GD, Nutt JG, Ritz B, Samii A, Tanner CM, Van Broeckhoven C, Van Den Eeden SK, Wirdefeldt K, Zabetian CP, Dehem M, Montimurro JS, Southwick A, Myers RM, Trikalinos TA. PMID: 17052658; PMCID: PMC3636768.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    199. Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis. Neuroepidemiology. 2006; 27(3):117-21. Popat RA, Van Den Eeden SK, Tanner CM, Bernstein AL, Bloch DA, Leimpeter A, McGuire V, Nelson LM. PMID: 16946622.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    200. Head injury and Parkinson's disease risk in twins. Ann Neurol. 2006 Jul; 60(1):65-72. Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW. PMID: 16718702.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    201. Structural variants in the vesicular monoamine transporter do not contribute to sporadic Parkinson's disease. Mov Disord. 2006 Mar; 21(3):426-7. Glatt C, Almonte M, Taylor T, Edwards RH, Freimer N, Tanner C, Parkinson Study Group. PMID: 16450345.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    202. Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation. Parkinsonism Relat Disord. 2005 Sep; 11(6):367-73. Tröster AI, Pahwa R, Fields JA, Tanner CM, Lyons KE. PMID: 16103000.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCTClinical Trials
    203. Verification of self-report of zygosity determined via DNA testing in a subset of the NAS-NRC twin registry 40 years later. Twin Res Hum Genet. 2005 Aug; 8(4):362-7. Reed T, Plassman BL, Tanner CM, Dick DM, Rinehart SA, Nichols WC. PMID: 16176721; PMCID: PMC1262657.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    204. High-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med. 2005 Jul 19; 143(2):152-3; author reply 156-8. Marras C, Lang AE, Oakes D, McDermott MP, Kieburtz K, Shoulson I, Tanner CM, Fahn S. PMID: 16027463.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    205. Smell identification ability in twin pairs discordant for Parkinson's disease. Mov Disord. 2005 Jun; 20(6):687-93. Marras C, Goldman S, Smith A, Barney P, Aston D, Comyns K, Korell M, Langston JW, Ross GW, Tanner CM. PMID: 15719425.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    206. A responsive outcome for Parkinson's disease neuroprotection futility studies. Ann Neurol. 2005 Feb; 57(2):197-203. Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K, NET-PD Investigators. PMID: 15668964.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    207. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clin Trials. 2005; 2(6):509-18. Guimaraes P, Kieburtz K, Goetz CG, Elm JJ, Palesch YY, Huang P, Ravina B, Tanner CM, Tilley BC. PMID: 16422311.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    208. Levodopa and the progression of Parkinson's disease. N Engl J Med. 2004 Dec 09; 351(24):2498-508. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K, Parkinson Study Group. PMID: 15590952.
      View in: PubMed   Mentions: 501     Fields:    Translation:HumansCTClinical Trials
    209. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol. 2004 Oct; 56(4):532-9. Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, White LR. PMID: 15389895.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansCells
    210. PD or not PD? That is the question. Neurology. 2003 Jul 08; 61(1):5-6. Tanner CM. PMID: 12847146.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    211. Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation. Mov Disord. 2003 Jul; 18(7):758-63. Tan LC, Tanner CM, Chen R, Chan P, Farrer M, Hardy J, Langston JW. PMID: 12815654.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    212. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003 Jun 01; 157(11):1015-22. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM. PMID: 12777365.
      View in: PubMed   Mentions: 524     Fields:    Translation:Humans
    213. Benefits and risks of pharmacological treatments for essential tremor. Drug Saf. 2003; 26(7):461-81. Lyons KE, Pahwa R, Comella CL, Eisa MS, Elble RJ, Fahn S, Jankovic J, Juncos JL, Koller WC, Ondo WG, Sethi KD, Stern MB, Tanner CM, Tintner R, Watts RL. PMID: 12735785.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    214. Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies. Adv Neurol. 2003; 91:133-42. Tanner CM. PMID: 12442672.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    215. Plantation work and risk of Parkinson disease in a population-based longitudinal study. Arch Neurol. 2002 Nov; 59(11):1787-92. Petrovitch H, Ross GW, Abbott RD, Sanderson WT, Sharp DS, Tanner CM, Masaki KH, Blanchette PL, Popper JS, Foley D, Launer L, White LR. PMID: 12433267.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansPHPublic Health
    216. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial. Ann Neurol. 2002 May; 51(5):604-12. Shoulson I, Oakes D, Fahn S, Lang A, Langston JW, LeWitt P, Olanow CW, Penney JB, Tanner C, Kieburtz K, Rudolph A, Parkinson Study Group. PMID: 12112107.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCTClinical Trials
    Carlie's Networks
    Concepts (482)
    Derived automatically from this person's publications.
    Co-Authors (49)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department